Clinical Trial Update: A Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06) [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on evorpacept (ALX148) for advanced HER2-positive gastric cancer (ASPEN-06) noting that Phase 2 and Phase 3 cohorts are active but not cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma
• Gastric Cancer
• Gastroesophageal Junction Adenocarcinoma

Drugs mentioned

• Evorpacept (ALX148) (evorpacept)

Snippet

Sponsor: ALX Oncology Inc. | Conditions: Gastric Cancer, Gastroesophageal Junction Adenocarcinoma | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING